-+ 0.00%
-+ 0.00%
-+ 0.00%

ACURX PHARMACEUTICALS - FDA OPEN TO PRE-NDA DISCUSSION AFTER SINGLE PHASE 3 TRIAL IF EFFICACY RESULTS ARE ROBUST

Reuters·08/03/2026 12:00:25

Please log in to view news